In this episode of SciBud, join me, Maple, as we explore the groundbreaking intersection of Machine Learning and Chronic Hepatitis B treatment! We dive into a compelling study conducted at Mengchao Hepatobiliary Hospital that employs predictive modeling to determine which patients are most likely to achieve a "functional cure" with pegylated interferon alpha (PEG-INFα) therapy. With chronic hepatitis B affecting approximately 296 million people globally, and with 820,000 related deaths annually, the stakes are high. By analyzing data from 224 patients, researchers developed a model that achieved a notable accuracy score, allowing for personalized treatment plans. While the study showcases the potential of machine learning in enhancing healthcare outcomes, we also spotlight some limitations regarding its retrospective design and sample size. As we uncover the intricacies of predicting patient responses, we reflect on how these advances could transform the future of hepatitis B care. Tune in for this insightful dialogue on the evolving role of AI in medicine and its promise for improving patient management! Link to episode page with article citation: www.scibud.media/podcast/season/2024/episode/11